Foothill Ranch, CA (PRWEB) November 14, 2006
MedMarket Diligence has completed a comprehensive worldwide analysis of the market for drugs, devices and diagnostics in ophthalmology. Based on primary and secondary research among clinicians, manufacturers and other market stakeholders worldwide, the report provides extensively detailed incidence, prevalence, market size, growth, and forecast competitor shares per country and/or region for the United States, individual western European countries (UK, Germany, France, BeNeLux, Italy and Spain), Japan and other key international markets; Asia (India, Korea, Australia, Russia and China), the Americas (Canada, Mexico, Brazil) and Middle East and Africa categories.
"The global market for ophthalmology products currently stands at $22 billion annually, dominated by pharmaceuticals and eye care products," notes Patrick Driscoll, publisher of the report and president of MedMarket Diligence, LLC "These markets have the benefit of being well established but still ripe for growth, with many sectors showing double digit upside potential."
The MedMarket Diligence report on the worldwide ophthalmology market covers vision correction and treatment options for corneal diseases, glaucoma, cataract, and retinal diseases. The analysis details the device, drug and diagnostic markets globally and by country, making it arguably the most comprehensive ophthalmology market report available. Detailed product, technology, market and competitor data is provided on contact lenses, orthokeratology, corneal ring segments, refractive surgery (LASIK, custom LASIK or wavefront - guided laser surgery, conductive keratoplasty, laser epithelial keratomileusis - LASEK, phakic IOLs, photorefractive keratectomy, laser thermal keratoplasty), cataract surgery (phacoemulsification, hand-held instruments, IOLs), and treatments for retinal detachment (laser photocoagulation, cryopexy, pneumatic retinopexy, scleral buckle), glaucoma drugs/devices and treatments for macular degeneration.glaucoma drugs/devices, The report is detailed here. For additional details, contact Patrick Driscoll at 949-859-3401 or patrick-at-mediligence-dot-com.
About MedMarket Diligence
MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes the MedMarkets newsletter, a monthly analysis of the market implications of new medical technologies, and dedicated reports on technology markets. Until year-end 2006, a free three-month trial of MedMarkets is available. For additional details, contact Patrick Driscoll at email or call 949-859-3401 or toll-free (in the U.S.). 1-866-820-1357.